Niloufar Rahiman
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
-
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- Nanoparticle-Based Drug Delivery 8
-
- RNA Interference and Gene Delivery 6
- Ubiquitin and proteasome pathways 1
- Co-authors
- Mahmoud Reza Jaafari (10 shared papers)Leila Arabi (7 shared papers)Amirhossein Sahebkar (2 shared papers)Seyedeh Hoda Alavizadeh (6 shared papers)Prashant Kesharwani (3 shared papers)Zahra Tayarani‐Najaran (1 shared paper)Maryam Akaberi (1 shared paper)Yuliya V. Markina (1 shared paper)
In The Last Decade
Niloufar Rahiman
21 papers receiving 391 citations
Peers
Comparison fields: 5 of 74
- Molecular Medicine 44
- Biomaterials 87
- Pharmaceutical Science 38
- Oncology 90
- Immunology 55
Countries citing papers authored by Niloufar Rahiman
This map shows the geographic impact of Niloufar Rahiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niloufar Rahiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niloufar Rahiman more than expected).
Fields of papers citing papers by Niloufar Rahiman
This network shows the impact of papers produced by Niloufar Rahiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niloufar Rahiman. The network helps show where Niloufar Rahiman may publish in the future.
Co-authors
The 25 scholars most cited alongside Niloufar Rahiman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 62 | |
| 2 | 2022 | 52 | |
| 3 | 2018 | 50 | |
| 4 | 2022 | 38 | |
| 5 | 2023 | 38 | |
| 6 | 2022 | 26 | |
| 7 | 2022 | 21 | |
| 8 | 2024 | 19 | |
| 9 | 2025 | 13 | |
| 10 | 2025 | 11 | |
| 11 | 2022 | 11 | |
| 12 | 2025 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2023 | 6 | |
| 16 | 2021 | 6 | |
| 17 | 2024 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2025 | 3 | |
| 20 | 2025 | 1 |
About Niloufar Rahiman
Niloufar Rahiman is a scholar working on Biomaterials, Molecular Biology, Molecular Medicine, Oncology and Immunology, having authored 21 papers that have together received 393 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (6 papers), Curcumin's Biomedical Applications (5 papers), Immunotherapy and Immune Responses (4 papers), Advanced Drug Delivery Systems (3 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Cells and Metastasis (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Molecular Medicine (44 citations), Biomaterials (87 citations), Pharmaceutical Science (38 citations), Oncology (90 citations) and Immunology (55 citations). Niloufar Rahiman has collaborated with scholars based in Iran, India and Spain. Frequent co-authors include Mahmoud Reza Jaafari, Leila Arabi, Amirhossein Sahebkar, Seyedeh Hoda Alavizadeh, Prashant Kesharwani, Zahra Tayarani‐Najaran, Maryam Akaberi, Yuliya V. Markina, Thomas P. Johnston and Seyed Ahmad Emami. Their work appears in journals such as Journal of Controlled Release, Journal of Drug Delivery Science and Technology, International Journal of Pharmaceutics, Drug Delivery and Cancer Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.